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Background: Drug poisoning mortality in the US has risen rapidly but the drugs involved are frequently unspecified
on death certificates.
Methods: Reported and adjusted proportions of specific drug types involved in fatal drug poisonings were calculated
using vital statistics mortality data from 1999 to 2012. The adjusted proportions were those predicted to occur if at
least one specific type of drug had been identified on the death certificates of all poisoning fatalities.
Results: Adjusted involvement rates of opioid analgesic mentions in 2012 were 54.3 % (95 % confidence interval [CI]:
53.6 %–55 %), 40.8 % higher than the reported 38.6 % rate. Adjusted rates for all narcotics, other narcotics, sedatives,
or psychotropics, and multiple drug use were 81.5 % (95 % CI: 80.9 %–82.2 %), 38.4 % (95 % CI: 37.8 %–39 %), 30 %
(95 % CI: 29.4 %–30.7 %), 26 % (95 % CI: 25.4 %–26.6 %) and 42.8 % (95 % CI: 42.1 %–43.5 %) in 2012, compared to
reported proportions of 60.7, 27.9, 18.7, 18 and 26.9 %. The adjustments typically had similar or slightly smaller effects
on the estimates in 1999, and larger impacts on subcategories of drug types such benzodiazepines and antipsychotic
medications. Based on the adjusted proportions, 22,534, 15,933, 12,457, 10,798, and 17,670 drug deaths in 2012 were
estimated to involve opioid analgesics, other narcotics, sedatives, psychotropic medications, and drug combinations,
compared to death certificate reports of 16,007, 11,567, 7,754, 7,467, and 11,176.
Conclusions: Death certificates substantially understate the involvement of opioid analgesics, sedatives, psychotropics,
and drug combinations in fatal drug poisonings. Adjustment procedures that account for cases where only unspecified
drugs are reported on death certificates provide more accurate information.
Keywords: Fatal drug poisonings, Drug poisoning mortality, Drug involvement, Poisoning deaths, Death certificates
Background
The poisoning mortality rate roughly tripled over the
last three decades, with about 90 % of these fatalities
now caused by drugs [1]. At least 80 % of drug fatalities
were accidental in 2011 and these are now the leading
cause of injury deaths [2]. Increased rates of poisoning
deaths are the most important reason for the striking
result that the all-cause mortality rates of 45–54 year
old non-Hispanic whites rose by around 0.5 % per
year between 1999 and 2013 [3]. The involvement of
prescription opioid analgesics, such as oxycodone, metha-
done, and hydrocodone has received considerable atten-
tion [1, 4–7]. But drug poisonings are not limited to
opioids – sedatives and psychotropic drugs are frequently
identified on death certificates, and combination drug use
is common [8, 9].
There are several barriers to formulating the most
effective policies to deter dangerous use of prescription
pharmaceuticals while avoiding the potential substitution
to other harmful legal or illegal drugs. Perhaps most
important is that we do not currently have reliable
information on the specific drugs involved in fatal
drug poisonings because no specific drug is identified
on almost one-quarter of death certificates. As a result,
rates of involvement for specific legal and illegal drugs
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are underestimated, as is the simultaneous use of drug
combinations.
This study provides a more accurate understanding of
the nature of drug poisoning deaths by using statistical
methods that account for cases where no specific drug is
identified on death certificates, to estimate the propor-
tions of specific drug mentions and combination drug
use for all types of drug poisoning mortality, as well as
separately by manner of death (accidental, intentional or
undetermined) and for two age groups (15–59 and
≥60 year olds). Adjusted counts of fatal drug poisonings
involving specified drug types are also calculated and
contrasted with those based on death certificate reports.
Data come from the 1999–2012 Centers for Disease
Control and Prevention (CDC) Multiple Cause of Death
(MCOD) files, described in detail elsewhere [10].
Methods
The MCOD files are based upon death certificates. Each
certificate contains a single underlying cause of death,
up to 20 additional causes, and demographic data. Infor-
mation is utilized on cause of death, using four-digit
International Classification of Diseases, Tenth Revision
(ICD-10) codes, place of residence, age, race/ethnicity,
gender, year, and weekday of death. The public use files
lack geographic identifiers for most years; however,
information on the state and county of residence, available
under restricted conditions, was obtained and used for
this analysis. The Institutional Review Board for the Social
and Behavioral Sciences at the University of Virginia
reviewed this project and determined that it does not
involve the use of human subjects.
The investigation is limited to deaths occurring to
US residents (foreign residents dying in the US were
excluded). The main analysis begins in 1999 because
ICD-9 codes, used prior to that year, are not fully com-
parable to ICD-10 categories [11]. Poisoning and drug
poisoning deaths were defined using ICD-10 underlying
cause of death (UCD) codes, where the UCD is the
“disease or injury that initiated the chain of morbid events
that led directly and inevitably to death” [12]. Poisoning
deaths included ICD-10 codes X40-X49, X60-X69, X85-
X90 Y10-Y19; Y35.2; *U01(.6-.7); ICD-10 codes for drug
poisoning deaths were X40-X44, X60-X64, X85, Y10-Y14;
Y35.2; *U01(.6-.7) [13].
In cases of drug poisoning, the death certificate lists
one or more drugs involved as immediate or contribu-
tory causes of death. These were included separately in
the MCOD files as ICD-10 “T-codes” and are referred to
below as drug mentions. Specific drug categories exam-
ined include: narcotics, sedatives, psychotropics, other
specified drugs, and unspecified drugs. Important subcat-
egories of drug involvement were also analyzed. Narcotics
were decomposed into (prescription) opioid analgesics
and other narcotics; opioid analgesics into methadone and
other opioid analgesics; other narcotics into heroin, co-
caine, and other non-analgesic opioids. Benzodiazepines
were sometimes separately broken out as an important
subclass of sedatives. Among psychotropic medications,
antidepressants, antipsychotics, and stimulants were sep-
arately examined. Other specified drugs comprised a wide
variety of medications including anesthetics, antiallergic
and immunosuppressive drugs, histamine and anti-gastric
secretion medications, cardiac drugs, antibiotics and many
others; deaths involving these drugs occurred relatively
rarely and so were examined as a group. Poisoning by
unspecified drugs, medicaments and biologicals (ICD-10
code, T50.9) was important because no specific drug was
identified for approximately one-quarter of drug poisoning
deaths. Combination drug use was examined through a
constructed variable indicating mentions of two or
more of the following drug categories: opioid analge-
sics, other opioids, sedatives, psychotropics, or other
specified drugs.
Numbers and percentages of drug poisoning deaths
were specified by type of drug, with the shares sometimes
referred to as proportions below. Results are reported for
1999 and 2012, the first and last analysis years. Shares
were also computed for subsamples of drug poisonings
stratified by whether they were classified based on the
underlying cause of death as accidental (UCD codes:
X40-44), intentional (X60-64), of undetermined intent
(Y10-Y14), or resulting from homicide/legal intervention
(X85, Y35.2, *U01(.6-.7)). Proportions were also calculated
separately for 16–59 and ≥60 year olds. Results are not
shown for drug deaths involving persons younger than 16
because these occur too rarely (92 cases in 1999 and 147
in 2012) for adjusted proportions to be reliably estimated.
Table 1 shows ICD-10 codes for each drug mention and
manner of death category [14].
A dichotomous variable was constructed indicating if
at least one specific drug was identified on the death
certificate, rather than only the unspecified drug cat-
egory being listed. State-year and county-year averages
of this variable were calculated, with the latter denoted
as SPECIFY. States were classified as “low diagnosis” if
mention of a specific drug was provided in fewer than
68.8 % of drug poisoning deaths in both 1999 and 2012
and as “high diagnosis” if this was done on more than
89.6 % of cases in both years (Additional file 1). These
thresholds reflected the 25th and 75th percentiles of drug
specification rates over the 1999–2012 period. The
within-state correlation in this variable across 1999 and
2012 was large but not perfect (r = 0.851).
Drug mention and manner of death shares were
compared across high and low diagnosis states for
1999 and 2012 to provide a first indication of how re-
ported proportions were affected by the frequent failure to
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identify any of the specific drugs involved in fatal drug
poisonings. Such comparisons will not be fully informative
if high and low diagnosis states differ along other dimen-
sions. To control for potential confounding factors, a
series of probit models were separately estimated for 1999
and 2012.
Probit is a nonlinear regression model specifically
designed for binary dependent variables, such as drug
mentions. It is similar to logit (logistic) regression except
that the cumulative distribution function of the error
term has a standard normal, rather than logistic, distri-
bution [15]. The basic probit model took the form:
Y ijt ¼ αþ β SPECIFY jt þ γXijt þ μijt; ð1Þ
where Yijt was a binary dependent variable indicating if
the death for individual i in county j and year t was
reported to involve the specified drug type. SPECIFY,
the explanatory variable of primary interest, measured
the county-year drug specification rate. μ is a regres-
sion error term.
Predictive power of the model was improved by includ-
ing supplementary covariates (X) capturing the effects of
characteristics related to the likelihood of the specified
drug being involved in the death but not caused by county
differences in SPECIFY. The main specifications included
controls for: gender, two race indicators (black and other
nonwhite), being married at the time of death (versus
never married, separated/divorced, widowed, or status
not reported), four educational categories (less than
high school graduate, high school graduate, some col-
lege, college graduate, with education not reported as the
reference group), eight age categories (≤20, 21–30, 31–40,
41–50, 51–60, 61–70, 71–80, >80, with missing age as the
Table 1 Drug involvement in drug poisoning deaths: 1999 and 2012a
Drug category/Manner of death 1999 2012
Percent Number Percent Number
All drug deaths (X40-44, X60-64, X85, Y10-14, Y35.2, *U01(.6-.7))b 100.0 16,849 100.0 41,502
Drug mentions (T-codes)
Narcotics (40.0-40.9) 58.9 9922 60.7 25,187
Opioid analgesics (40.2-40.4) 23.9 4030 38.6 16,007
Methadone (40.3) 4.7 784 9.5 3932
Other opioid analgesics (40.2, 40.4) 19.9 3360 31.4 13,012
Other narcotics (40.0–40.1, 40.5–40.9) 42.4 7137 27.9 11,567
Heroin (40.1) 11.6 1960 14.3 5925
Cocaine (40.5) 22.7 3822 10.6 4404
Miscellaneous (40.0, 40.6–40.9) 17.4 2931 7.2 3006
Sedatives (40.2–40.8) 9.9 1662 18.7 7754
Benzodiazepines (42.4) 6.7 1135 15.7 6524
Other sedatives (42.0–42.3, 42.5–42.8) 3.9 663 4.9 2048
Psychotropics (43.0–43.9) 14.6 2466 18.0 7467
Antidepressants (43.0–43.2) 10.4 1749 10.3 4259
Antipsychotics (43.3–43.5) 1.9 321 3.2 1333
Stimulants (43.6) 3.2 547 6.3 2635
Other specified (36.0–38.9, 41.0, 41.9, 44.0–48.7, 49.0–50.8) 6.9 1171 7.6 3156
Unspecified (50.9) 50.3 8477 49.7 20,612
>1 Major drug classc 18.0 3040 26.9 11,176
Manner of death
Accidental (X40–44) 66.2 11,155 79.9 33,175
Intentional (X60–64) 18.9 3181 13.2 5465
Undetermined intent (Y10–Y14) 14.7 2473 6.7 2782
Homicide (X85, Y35.2, *U01(.6–.7)) 0.2 40 0.2 80
aData from the Multiple Cause of Death files
bEntries in parentheses refer to ICD-10 X and Y codes for the underlying causes of death used to classify drug poisoning and manner of death, and T codes for
drug mentions
cTwo or more of the drug types: opioid analgesics, other narcotics, sedatives, psychotropics, or other specified drugs
Ruhm Population Health Metrics  (2016) 14:2 Page 3 of 12
reference group), nine census regions (New England,
Mid-Atlantic, East North Central, West North Central,
South Atlantic, East South Central, West South Central,
Mountain and Pacific), and seven day of the week of death
indicators. Education was sometimes reported in years
rather than specific thresholds. In these cases, ≤11, 12,
13–15, and ≥16 years were classified as less than high
school graduate, high school graduate, some college, and
college graduate. Manner of death was not controlled for
in the primary specifications, because of evidence pro-
vided below that classification varies with county-level
drug specification rates and previous research indicating
that death certificates sometimes misclassify intentional
drug fatalities as being accidental or of undetermined
intent [16, 17]. Supplementary models added controls
for the manner of death (accidental or intentional, with
undetermined intent/homicide as the reference group)
allowing for proportions to be compared with and without
the inclusion of these supplementary controls.
Predicted values of the dependent variable were calcu-
lated for each drug poisoning death and then averaged
over all observations to obtain estimated proportions.









i¼1Φ α^ þ β^ Specif yjt þ γ^Xijt
 
; ð2Þ
for Φ(.), the cumulative distribution function of the stand-
ard normal distribution. Since these predictions were
based on actual values of the explanatory variables, the
estimated proportions were expected to be similar to the
sample mean values. This was tested for and confirmed
for all types of drug mentions in both 1999 and 2012
(Additional file 2).
Next, a second set of predicted values was obtained
after setting SPECIFY to one for all observations. The
average expected value, hereafter referred to as the
“adjusted proportion”, ~P˜jt , was estimated as:
~P˜jt ¼ 1n
Xn
i¼1Φ α^ þ β^ þ γ^Xijt
 
; ð3Þ
and indicates the drug involvement rate expected if at
least one specific drug type had been identified on all
drug poisoning death certificates. Ninety-five percent con-
fidence intervals (95 % CI) were calculated using the delta
method.
The predicted number of deaths involving the speci-
fied class of drugs, ~D˜jt , was computed as the product of
the adjusted proportion and number of drug poisoning
deaths in year t, Dt, or:
~D˜jt ¼ ~P˜jt  Dt ; ð4Þ
The associated lower (upper) threshold of the 95 % CI
was computed as the product of the number of drug
fatalities times the lower (upper) value of the adjusted
proportion 95 % CI.
Although there is no single agreed-upon measure of
goodness-of-fit in probit or logit models (corresponding
to R2 in a regression framework), a common measure
used here is the pseudo-R2, defined as 1 −ℒur/ℒ0, where
ℒur is the log-likelihood function of the estimated speci-
fication and ℒ0 is the log-likelihood function of the
intercept-only model [18]. Two additional indications of
the success of the adjustment procedures were examined.
The first compared reported and adjusted shares of exclu-
sive unspecified drug mentions (those where no drug was
identified on the death certificate). As mentioned, the re-
ported proportion was approximately 25 % in most years.
Completely successful adjustment procedures would re-
duce this to zero, and estimated shares close to this would
provide confidence in the adjustment procedure. The
second test was the reverse of the first. Here, adjusted
proportions were calculated using the same procedure but
assuming that drug types were never specified on the
death certificates, by predicting proportions after setting
SPECIFY to zero as: ~P˜jt ¼ 1n
Xn
i¼1Φ α^ þ γ^Xijt
 
. Perfect
adjustment would imply exclusive mentions of unspecified
drugs in 100 % of drug fatalities. Predicted probabilities
can never reach zero or one in a probit model, so that
complete adjustment will never be achieved.
Analyses were conducted using STATA Statistical
Software: Release 14 [19]. Statistical significance refers
to P < .05, from two-sided tests.
Results
Trends in drug poisoning and specific drug mention rates
Drug deaths rose 146 % between 1999 and 2012, from
16,849 to 41,502. The national population grew by 12.5 %
and the total number of deaths by 6.4 % over the same
period, so that the (non-age-adjusted) fatal poisoning rate
increased by 119 % from 6.04 to 13.22 per 100,000 and
from 0.70 % to 1.55 % of all deaths. Poisoning mortality of
all types grew 134 % (from 19,741 to 46,150) between
1999 and 2012, and drug fatalities as a share of poisoning
deaths increased from 85 % in 1999 to 92 % in 2006,
before declining slightly to 90 % in 2012 (Fig. 1). The rise
in drug mortality represents an acceleration of a trend that
started in the early 1980s. In 1982, 6518 individuals died
from drugs, or 2.81 per 100,000 population, and these
constituted 58 % of all poisoning fatalities [1]. The drug
poisoning death rate grew 4.6 % annually between 1982
and 1999 (from 2.81 to 6.04 per 100,000) versus 6.2 % per
year from 1999 to 2012 (from 6.04 to 13.22 per 100,000).
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One or more specific drugs were mentioned for 78.1, 73.1,
and 75.8 % of drug fatalities in 1999, 2008, and 2012
(Fig. 2).
Death certificate reports
Narcotics were identified in 60.7 % of all 2012 drug fatal-
ities, slightly above 58.9 % in 1999 (Table 1). This reflected
a rapid increase in opioid analgesic mentions (from 23.9 %
to 38.6 %) and heroin-involved deaths (from 11.6 % to
14.2 %) that more than offset substantial reductions in
reported shares of cocaine and miscellaneous narcotics.
However, since drug deaths increased dramatically be-
tween 1999 and 2012 (from 16,849 to 41,502), the number
of drug mentions sometimes increased even while propor-
tions declined. For example, cocaine mentions grew from
3822 to 4404 fatalities while the corresponding share of
drug deaths fell from 22.7 % to 10.6 %.
These overall patterns conceal heterogeneity within
drug classes. Methadone mentions more than quintupled
over the 13 years, while other opioid analgesic involve-
ment less than quadrupled. The 367 % increase in sedative
involvement was largely due to the 475 % rise in benzodi-
azepine mentions, and reported psychotropic drug men-
tions grew 203 %, led by 382 % and 315 % increases in
stimulant and antipsychotic involvement. Mentions of
other specified drugs rose 170 %. Also noteworthy was the
rise from 8477 to 20,612 in unspecified drug involvement
that exceeded opioid analgesic mentions by 29 % in 2012.
Drug combinations were reported in 18 % fatal drug
poisonings in 1999 and 27 % in 2012.
Fig. 1 Poisoning and drug poisoning mortality rates
Fig. 2 Drug specification rate
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The classified manner of drug fatalities changed over
time, with the share of accidental poisonings rising from
66 % to 80 % between 1999 and 2012, while intentional
deaths fell from 19 % to 13 % and those of undetermined
intent from 15 % to 7 %; homicides represented a minis-
cule 0.2 % of drug poisoning fatalities in both years
(bottom panel of Table 1).
Adjusted shares
Death certificates understate most drug involvement
proportions because of the frequency of cases where
no specific drug was identified. A first indication of this
was obtained by comparing death certificate reports in
high and low diagnosis states (Table 2). As expected, the
reported proportions were almost always greater in the
high diagnosis locations. For example, narcotics involve-
ment in 2012 was 78.3 % in high diagnosis states versus
41.1 % in those with low diagnosis rates. Substantial
differences were obtained for opioid analgesics, sedatives,
psychotropics, and combination drug use, while unspeci-
fied drugs were less commonly mentioned, with 36.5 %
for high versus 68.4 % for low diagnosis in 2012. One
exception is that heroin mentions were more prevalent in
low than high diagnosis states in 1999 (but not 2012).
This comparison does not account for potential
confounders. As evidence that these may matter, drug
poisoning rates almost tripled in the low diagnosis states
(from 5.0 to 14.1 per 100,000) between 1999 and 2012
compared to less than doubling (from 7.0 to 13.4 per
100,000) in high diagnosis areas. There are also substan-
tial differences in the classified manner of deaths, with
accidental fatalities being more common and those with
undetermined intent being less frequent in low than in
high diagnosis states. To the extent that these represent
differences in reporting patterns rather than actual
mechanisms of death, errors may be introduced when
Table 2 Drug involvement in drug poisoning deaths in high and low diagnosis statesa
Drug category/Manner of death 1999 2012
Low diagnosis statesb High diagnosis statesc Low diagnosis statesb High diagnosis statesc
Drug mentions
Narcotics 35.9 76.1 41.1 78.3
Opioid analgesics 13.4 23.8 24.7 52.1
Other narcotics 25.0 60.7 20.0 36.5
Heroin 10.8 7.9 12.2 18.5
Cocaine 13.5 29.3 6.6 13.5
Sedatives 5.6 11.0 10.6 24.8
Benzodiazepines 3.8 7.4 9.0 20.2
Psychotropics 7.7 17.0 8.5 23.9
Antidepressants 6.1 13.2 5.9 14.7
Antipsychotics 1.0 2.4 1.5 4.6
Stimulants 1.0 3.2 1.9 7.2
Other specified 7.4 6.4 4.9 11.0
Unspecified 66.7 30.7 68.4 36.5
>1 Major drug classd 8.1 21.5 15.1 39.8
Drug poisoning ratee 5.04 7.00 14.09 13.37
Manner of death
Accidental 64.1 % 49.6 % 80.6 % 73.5 %
Intentional 19.1 % 16.1 % 10.9 % 13.5 %
Undetermined intent 16.2 % 34.0 % 8.3 % 12.9 %
Homicide 0.6 % 0.3 % 0.2 % 0.1 %
aData from the Multiple Cause of Death files
bLow diagnosis states, defined as those with at least one drug specified for fewer than 68.8 % of drug poisoning deaths in both 1999 and 2012, include: Alabama,
Idaho, Indiana, Louisiana, Michigan, Mississippi, Montana, Nebraska, North Dakota and Pennsylvania
cHigh diagnosis states, defined as those with at least one drug specified for more than 89.6 % of drug poisoning deaths in both 1999 and 2012 include: Alaska,
Maryland, Massachusetts, Nevada, New Hampshire, New York, Oklahoma, Rhode Island, Utah, Virginia and Washington
dTwo or more of the drug types: opioid analgesics, other narcotics, sedatives, psychotropics, or other specified drugs
eDrug poisoning rate is per 100,000 population
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including the controls for the manner of death when
estimating adjusted proportions or when examining
differences in shares across reported manners of drug
deaths.
Table 3 displays reported and adjusted proportions,
as well as percentage differences between the two, for
1999 and 2012. As mentioned, adjusted involvement
was estimated from probit models that account for
spurious correlation related to differences in age, sex,
race/ethnicity, educational attainment, census region,
and the weekday of the death, and calculated under
the assumption that at least one specific drug was
identified for each drug poisoning fatality.
The adjustment procedures significantly raised the pre-
dicted frequency of all specific drug proportions, implying
that death certificates understated most types of drug
involvement. For example, the adjusted proportion of
opioid analgesic mentions in 2012 was 54.3 % (95 % CI,
53.6 %–55 %), or 40.8 % (95 % CI, 39 %–42.5 %) higher
than the reported 38.6 %. (Percentage differences vary
slightly on the table due to rounding. In the example just
shown, adjusted and reported proportions were actually
54.296 % and 38.569 %, and the difference between them
was 40.776 %).
Adjusted proportions for narcotics, psychotropics, other
specified drugs, and combination drug use exceeded re-
ported shares by 34 % to 46 %, while those for unspecified
drugs fell 31 %. The increase was a particularly large, at
60.7 % (95 % CI, 57.1 %–64.2 %) for sedatives – mostly
due to the 62.6 % (95 % CI, 58.6 %–66.5 %) growth for
benzodiazepines – and also for antipsychotics and antide-
pressants, where adjusted proportions exceeded reported
values by 65.1 % (95 % CI, 54.7 %–75.5 %) and 60.2 %
(95 % CI, 55 %–65.4 %). The adjustment procedure typic-
ally had similar or slightly smaller percentage effects on
drug shares in 1999.
An alternative set of adjusted proportions was obtained
from models that contained additional controls for the
manner of death (accidental or intentional, with undeter-
mined intent/homicides as the reference group). This
specification has the potential advantage of increased
predictive power, but will be problematic if classification
of the manner of death depends on drug specification
rates, as was suggested above. In practice, the adjusted
shares were virtually identical to those obtained from the
main model (Additional file 3).
Table 4 details adjusted proportions and percentage
differences compared to death certificate reports in 1999
and 2012 for subsamples stratified by whether the fatal
drug poisoning was classified as accidental, intentional,
or of undetermined intent. Results for homicides are
not reported since these accounted for just 0.2 % of
drug mortality. (Additional file 4 shows reported pro-
portions). Patterns of drug involvement vary substantially
Table 3 Reported and adjusted drug involvementa
Drug category % [95 % CI]
1999 2012
Reportedb Adjustedc % Differenced Reportedb Adjustedc % Differenced
Narcotics 58.9 77.8 [76.9–78.7] 32.2 [30.6–33.7] 60.7 81.5 [80.9–82.2] 34.3 [33.2–35.4]
Opioid analgesics 23.9 31.3 [30.2–32.4] 30.9 [26.2–35.6] 38.6 54.3 [53.6–55.0] 40.8 [39.0–42.5]
Other narcotics 42.4 58.3 [57.2–59.3] 37.6 [35.1–40.1] 27.9 38.4 [37.8–39.0] 37.7 [35.5–40.0]
Heroin 11.6 14.1 [13.3–14.9] 20.9 [14.2–27.7] 14.3 20.0 [19.4–20.5] 39.9 [36.2–43.6]
Cocaine 22.7 31.1 [30.0–32.1] 37.0 [32.4–41.6] 10.6 14.9 [14.4–15.3] 40.0 [35.5–44.5]
Sedatives 9.9 15.6 [14.7–16.6] 58.4 [48.8–68.0] 18.7 30.0 [29.4–30.7] 60.7 [57.1–64.2]
Benzodiazepines 6.7 11.4 [10.6–12.3] 69.6 [56.8–82.3] 15.7 25.6 [24.9–26.2] 62.6 [58.6–66.5]
Psychotropics 14.6 21.2 [20.1–22.2] 44.7 [37.7–51.7] 18.0 26.0 [25.4–26.6] 44.6 [41.2–48.0]
Antidepressants 10.4 16.3 [15.4–17.3] 57.1 [47.9–66.3] 10.3 16.4 [15.9–17.0] 60.2 [55.0–65.4]
Antipsychotics 1.9 3.2 [2.7–3.7] 68.9 [43.0–94.7] 3.2 5.3 [5.0–5.6] 65.1 [54.7–75.5]
Stimulants 3.2 3.9 [3.4–4.4] 19.9 [5.3–34.6] 6.3 7.9 [7.5–8.3] 24.4 [18.6–30.2]
Other specified 6.9 8.8 [8.1–9.5] 26.6 [16.8–36.3] 7.6 10.9 [10.5–11.3] 43.5 [37.8–49.2]
Unspecified 50.3 35.4 [34.3–36.5] −29.6 [−31.7 – −27.4] 49.7 34.1 [33.4–34.7] −31.4 [−32.7 – −30.2]
>1 Major drug classe 18.0 28.6 [27.5–29.8] 58.6 [52.2–64.9] 26.9 42.8 [42.1–43.5] 58.9 [56.3–61.5]
aData from the Multiple Cause of Death files
bProportions from death certificate reports
cAdjusted proportions are average predicted values from probit models, where at least one specific drug is assumed to be mentioned for all poisoning deaths
(SPECIFY = 1). Models also control for: sex, race (black, other), Hispanic, currently married, education (high school dropout, high school graduate, some college,
college graduate), age (≤20, 21–30, 31–40, 41–50, 51–60, 61–70, 71–80, >80), day of the week of death, and census region
d% Difference between adjusted and reported proportions (calculated using more precise proportions than the rounded percentages displayed on the table)
eTwo or more of the drug types: opioid analgesics, other narcotics, sedatives, psychotropics, or other specified drugs
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by manner of death, with narcotics – particularly non-
analgesics – being much more commonly involved for
accidental fatalities and those of undetermined intent;
whereas sedatives, psychotropics, and other specified and
unspecified drugs played bigger roles for intentional drug
deaths. However, there were no clear patterns of percent-
age differences in adjusted versus reported proportions
across years or manners of death.
Adjusted shares and percentage differences versus re-
ported drug involvement are shown separately for 16–59
and ≥60 year olds in Table 5. (Additional file 5 provides
corresponding reported proportions). Information for
persons younger than 16 is not displayed since they
accounted for less than 0.6 % of drug fatalities. There
were more than eight times as many drug deaths among
16–59 year olds (15,484 in 1999 and 37,171 in 2012) as
≥60 year olds (1257 in 1999 and 4182 in 2012), generally
resulting in more precise adjusted proportions for the
younger group.
Compared to drug deaths involving persons 60 and
over, those among 16–59 year olds more often involved
narcotics of all kinds and combination drug use, with
other specified drugs less often implicated but with no
clear patterns for sedatives, psychotropics or unspecified
drugs. Reported proportions understate drug involve-
ment by similar amounts for the two age groups with
two exceptions: there was a particularly large downwards
bias in the share of other drugs for 16–59 year olds in
1999 and 2012, as well as for sedatives in 1999.
Number of deaths
The first and third columns of Table 6 show estimates
for the number of drug poisoning deaths involving major
categories of drugs, based on the adjusted proportions
detailed in Table 3. The second and fourth columns indi-
cate how these differ from the corresponding numbers
reported on death certificates. To illustrate, 22,534 drug
deaths were estimated to involve opioid analgesics in
2012, calculated as the adjusted proportion (54.296 %)
times the total number of drug poisoning deaths (41,502).
This number is 6527 above the 16,007 death certificates
mentioning this type of drug. The calculations use more
significant digits than reported on the tables, so that the
small differences occur compared to calculations based on
the rounded estimates.
Table 4 Adjusted drug involvement by manner of death and change vs. reported proportiona
Drug category % [95 % CI]
Accidental Intentional Undetermined intent
Adjustedb % Differencec Adjustedb % Differencec Adjustedb % Differencec
1999
Narcotics 86.9 [86.0–87.7] 29.9 [28.6–31.2] 36.2 [33.3–39.2] 52.2 [40.1–64.9] 81.0 [78.6–83.4] 18.8 [15.4–22.3]
Opioid analg. 34.6 [33.2–36.0] 33.1 [27.7–38.5] 28.9 [26.1–31.7] 52.1 [37.2–66.9] 25.7 [23.0–28.4] 23.1 [10.2–35.9]
Other narcotics 68.6 [67.4–69.9] 36.0 [33.5–38.4] 9.8 [7.9–11.6] 62.9 [32.0–93.7] 63.1 [60.3–65.8] 19.8 [14.6–25.0]
Sedatives 13.3 [12.2–14.4] 67.6 [53.6–81.7] 30.8 [28.0–33.7] 62.0 [47.0–77.1] 10.7 [8.5–12.9] 56.8 [24.5–89.2]
Psychotropics 15.9 [14.7–17.0] 46.7 [36.2–57.2] 45.0 [42.0–48.0] 55.7 [45.3–66.1] 18.8 [16.2–21.3] 40.2 [21.0–59.4]
Other specified 6.9 [6.2–7.6] 17.5 [5.8–29.1] 18.7 [16.3–21.1] 45.4 [26.9–64.0] 5.9 [4.3–7.6] 48.2 [7.2–89.1]
Unspecified 33.1 [31.8–34.4] −32.6 [−29.9 – −35.2] 55.0 [52.1–57.9] −16.4 [−12.0 – −20.9] 25.0 [22.4–27.5] −31.3 [−24.3 – −38.4]
>1 Drug classd 30.1 [28.7–31.5] 57.8 [50.4–65.3] 33.6 [30.5–36.7] 92.9 [75.2–110.6] 22.6 [19.8–25.4] 59.5 [39.8–79.2]
2012
Narcotics 87.4 [86.9–87.8] 32.9 [32.2–33.6] 44.4 [42.5–46.3] 38.7 [32.8–44.6] 76.9 [74.7–79.1] 35.8 [32.0–39.6]
Opioid analg. 56.5 [55.8–57.3] 41.4 [39.6–43.3] 40.0 [38.1–41.9] 39.6 [33.1–46.2] 57.7 [55.1–60.3] 38.5 [32.3–44.8]
Other narcotics 43.9 [43.2–44.6] 36.3 [34.0–38.5] 6.2 [5.2–7.1] 40.3 [18.7–62.0] 30.8 [28.4–33.1] 39.0 [28.3–49.6]
Sedatives 29.7 [29.0–30.4] 64.8 [60.7–68.9] 36.2 [34.3–38.0] 48.6 [40.9–56.2] 24.6 [22.2–27.0] 56.4 [41.1–71.7]
Psychotropics 23.6 [23.0–24.3] 44.8 [40.8–48.9] 41.4 [39.5–43.3] 46.9 [40.2–53.6] 27.0 [24.6–29.5] 50.9 [37.3–64.6]
Other specified 8.2 [7.8–8.7] 51.8 [43.9–59.8] 28.8 [27.1–30.5] 33.4 [25.5–41.3] 8.9 [7.3–10.5] 46.6 [20.2–73.0]
Unspecified 32.2 [31.5–32.9] −33.3 [−31.9 – −34.8] 48.6 [46.7–50.4] −18.2 [−15.1 – −21.3] 30.6 [28.2–32.9] −35.4 [−30.5 – −40.4]
>1 Drug classd 43.2 [42.4–44.0] 60.2 [57.3–63.1] 43.3 [41.3–45.2] 56.6 [49.7–63.6] 39.2 [36.5–41.9] 53.2 [42.8–63.7]
aData from the Multiple Cause of Death files
bAdjusted proportions are average predicted values from probit models, where at least one specific drug is assumed to be mentioned for all poisoning deaths
(SPECIFY = 1). Models also control for: sex, race (black, other), Hispanic, currently married, education (high school dropout, high school graduate, some college,
college graduate), age (≤20, 21–30, 31–40, 41–50, 51–60, 61–70, 71–80, >80), day of the week of death, and census region
c% Difference shows the percentage difference between adjusted proportions and those obtained directly from mentions on death certificates
dTwo or more of the drug types: opioid analgesics, other narcotics, sedatives, psychotropics, or other specified drugs
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Table 6 Adjusted number of drug poisoning deaths and change vs. reported numbersa
Drug category # [95 % CI]
1999 2012
Deathsb Δ vs. reportedc Deathsb Δ vs. reportedc
Narcotics 13,114 [12,962–13,265] 3192 [3040–3343] 33,830 [33,560–34,100] 8643 [8373–8913]
Opioid analgesics 5275 [5087–5463] 1245 [1057–1433] 22,534 [22,254–22,814] 6527 [6247–6807]
Other narcotics 9820 [9641–9999] 2683 [2504–2862] 15,933 [15,671–16,196] 4366 [4104–4629]
Sedatives 2633 [2473–2792] 971 [811–1130] 12,457 [12,185–12,729] 4703 [4431–4975]
Psychotropics 3568 [3395–3741] 1102 [929–1275] 10,798 [10,544–11,053] 3331 [3077–3586]
Other specified 1482 [1368–1596] 311 [197–425] 4528 [4348–4709] 1372 [1192–1553]
Unspecified 5930 [5786–6154] −2507 [−2691 – −2323] 14,135 [13,874–14,396] −6477 [−6738 – −6216]
>1 Major drug classd 4820 [4627–5013] 1780 [1587–1973] 17,670 [17,469–18,050] 6584 [6293–6874]
aData from the Multiple Cause of Death files
bNumber of drug poisoning deaths involving the specified drug, calculated as the product of the number of drug poisoning deaths in the year multiplied by the
adjusted proportion obtained from probit models, where at least one specific drug is assumed to be mentioned for all poisoning deaths (SPECIFY = 1). Models
also control for: sex, race (black, other), Hispanic, currently married, education (high school dropout, high school graduate, some college, college graduate), age
(≤20, 21–30, 31–40, 41–50, 51–60, 61–70, 71–80, >80), day of the week of death, and census region. The calculations use more significant digits for adjusted
proportions than are shown on Table 3, so that there may be small differences from those that would be obtained using rounded estimates
cDifference between adjusted number of deaths and unadjusted number based on death certificate reports
dTwo or more of the drug types: opioid analgesics, other narcotics, sedatives, psychotropics, or other specified drugs.
Table 5 Adjusted drug involvement by age group and change vs. reported proportiona
Drug category % [95 % ci]
16–59 year olds ≥60 year olds
Adjustedb % Differencec Adjustedb % Differencec
1999
Narcotics 81.1 [80.2–82.0] 31.4 [29.9–32.8] 36.5 [32.3–40.7] 39.5 [23.3–55.7]
Opioid analgesics 32.0 [30.8–33.2] 30.4 [25.6–35.1] 23.4 [19.5–27.3] 42.0 [18.1–65.9]
Other narcotics 61.8 [60.7–62.9] 37.3 [34.8–39.8] 16.6 [13.6–19.6] 40.7 [15.2–66.2]
Sedatives 15.2 [14.3–16.2] 60.8 [50.5–71.2] 20.8 [17.0–24.6] 39.2 [13.8–64.6]
Psychotropics 21.3 [20.3–22.4] 44.4 [37.2–51.7] 20.3 [16.5–24.1] 52.8 [24.1–81.5]
Other specified 6.7 [6.1–7.4] 38.3 [24.8–51.9] 32.3 [28.2–36.4] 3.8 [−9.2–16.9]
Unspecified 35.4 [34.3–36.6] −30.5 [−28.2 – −32.7] 36.7 [32.5–40.8] −15.9 [−6.4 – −25.3]
>1 Major drug classd 29.6 [28.4–30.8] 58.2 [51.8–64.7] 18.3 [14.6–22.1] 63.5 [30.0–97.0]
2012
Narcotics 83.4 [82.9–84.0] 34.2 [33.4–35.0] 64.0 [62.1–66.0] 35.2 [31.1–39.4]
Opioid analgesics 54.9 [54.2–55.6] 41.0 [39.2–42.9] 48.9 [46.7–51.1] 39.2 [33.1–45.3]
Other narcotics 40.6 [39.9–41.3] 38.2 [35.9–40.5] 20.2 [18.6–21.8] 34.4 [23.8–45.0]
Sedatives 30.2 [29.6–30.9] 60.7 [57.0–64.4] 28.8 [26.7–30.8] 60.5 [49.1–71.8]
Psychotropics 25.9 [25.2–26.5] 44.8 [41.1–48.4] 27.5 [25.6–29.5] 44.0 [33.8–54.3]
Other specified 9.6 [9.2–10.1] 48.6 [41.8–55.5] 22.5 [20.8–24.2] 28.9 [19.1–38.8]
Unspecified 34.1 [33.4–34.7] −31.9 [−30.5 – −33.2] 34.5 [32.5–36.5] −26.7 [−22.5 – −30.9]
>1 Major drug classd 43.6 [42.9–44.4] 58.8 [56.1–61.5] 36.4 [34.2–38.5] 60.8 [51.3–70.3]
aData from the Multiple Cause of Death files
bAdjusted proportions are average predicted values from probit models, where at least one specific drug is assumed to be mentioned for all poisoning deaths
(SPECIFY = 1). Models also control for: sex, race (black, other), Hispanic, currently married, education (high school dropout, high school graduate, some college,
college graduate), age (≤20, 21–30, 31–40, 41–50, 51–60, 61–70, 71–80, >80), day of the week of death, and census region
c% Difference shows the percentage difference between adjusted proportions and those obtained directly from mentions on death certificates
dTwo or more of the drug types: opioid analgesics, other narcotics, sedatives, psychotropics, or other specified drugs
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The adjustments raise the number of deaths involving
all specific drug categories, while reducing the role of
unspecified drugs. Larger increases were observed in
2012 than in 1999, as expected given the dramatic
growth in total drug poisoning mortality, and these
differences show the extent to which death certificates
inaccurately indicate trends in drug involvement. The
biggest absolute disparities were for opioid analgesics:
6527 deaths (95 % CI 6247–6807) in 2012 versus 1245
(95 % CI 1057–1433) in 1999 and combination drug use
6584 deaths (95 % CI 6293–6874) versus 1780 (95 % CI
1587–1973). However, the greatest relative differences
were for sedatives and psychotropic medications.
(Additional file 6 shows results for drug subcategories).
Discussion
The information currently provided on death certificates
is inadequate for understanding the nature of the drug
poisoning epidemic. Particularly problematic is the fre-
quency with which no specific drug is identified [20].
Since this is more common when death certificates are
completed by coroners rather than medical examiners
and in states without centralized oversight by a Chief
Medical Examiner [21], additional training and stan-
dardization in states with low drug specification rates
may be helpful. Others have also recommended includ-
ing more detail on the drugs involved in poisoning
deaths, toxicology levels of opioids, whether or not these
were prescribed to decedent, and more detailed opioid
toxicology ICD categories [22, 23].
Until better information becomes available, the pre-
dictive adjustment methods developed here can provide
more accurate estimates of specific drug involvement.
The adjustments are substantial, as death certificates
understated mentions of major classes of drugs by 27 %
to 58 % in 1999 and by 34 % to 61 % in 2012 and com-
bination drug use by 59 % in both years, with even larger
changes for some subcategories of drugs (e.g. antipsy-
chotics and benzodiazepines). Underlying causes of death
are also inaccurately recorded because they are classified
based upon reported drug mentions. For example, nar-
cotics was classified as the UCD in 46.4 % of drug poison-
ing cases in 1999 and 37.6 % in 2012, compared to
adjusted rates of 59.6 % and 48 % respectively, using the
procedures to described above (Additional file 7).
The adjustment procedures work well, but not perfectly.
As evidence of this, reported proportions of exclusive
unspecified drug mentions were 21.9 % in 1999 and
24.2 % in 2012, while the adjusted shares were 4.3 % and
3.7 %. Completely successful adjustment would reduce
the adjusted proportion to zero, indicating that 80 %
and 85 % (rather than 100 %) of such mentions were
eliminated. Adjusted proportions calculated under the
assumption that drug types were never specified on
the death certificates (by predicting probabilities after
setting SPECIFY = 0) were 96.4 % in 1999 and 96.5 %
in 2012, which is close to the 100 % adjusted share occur-
ring with perfect prediction. These favorable results occur
even though goodness-of-fit, as measured by the pseudo-
R2, which ranges between 0.06 and 0.33, implies a limited
ability to predict drug use in individual cases. This does
not necessarily indicate inaccuracy in the overall estimates
of adjusted proportions, but could be problematic if unob-
served determinants of drug involvement were spuriously
correlated with county-level specification rates.
Better understanding is also needed of the situations
under which the unspecified drug category (T50.9) is
reported on death certificates. The procedures developed
here adjust for cases where unspecified drugs are exclu-
sively mentioned (i.e., when death certificates report a
drug poisoning without identifying any of the drugs
involved). However, in many cases there are mentions of
both specified and unspecified drugs. These sometimes
occur when “multidrug toxicity” or something similar,
is listed on one part of the death certificate but with
more specific information, such as heroin use, reported on
another part (source: personal communication with Robert
Anderson, Chief of the Mortality Statistics Branch of
the National Center for Health Statistics, October 2,
and October 6, 2015).
In 1999, 16,849 US residents died of drug poisoning.
By 2012, the number had risen to 41,502. Mentions of
opioid analgesic almost quadrupled, from 4030 to 16,007,
but the adjusted estimates indicate an even larger increase
in opioid involvement from 5275 deaths (95 % CI 5087–
5463) in 1999 to 22,534 (95 % CI 22,254–22,814) in 2012.
These figures imply that these drugs were mentioned in
54.3 % (95 % CI, 53.6 %–55 %) of fatal drug poisonings in
the later year. Such results justify efforts to reduce the
negative consequences of prescription opioid use, includ-
ing establishing prescription drug monitoring programs;
restrictions on the dispensing of oxycodone and other
controlled substances from pain clinics and online phar-
macies; and development of abuse-deterrent drug formu-
lations [24–28]. These endeavors have been somewhat
successful. Drug poisoning deaths in Florida decreased
17 % between 2010 and 2013, with a 52 % decline in fatal-
ities involving oxycodone following aggressive efforts to
reverse the proliferation of pain clinics, prohibit the dis-
pensing of schedule II or III drugs from physician offices,
and other measures [29]. Deaths involving methadone
peaked in 2007 and then declined along with a fall in
the amount of methadone distributed nationally [5]. How-
ever, the accomplishments are incomplete. After Florida’s
crackdown, some pain clinic owners moved out of the
state or found ways to circumvent the laws, and it is ques-
tionable whether prescription drug monitoring programs
have reduced drug poisoning deaths [24, 29, 30]. Most
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notably, fatalities involving heroin have doubled since
2004, raising the possibility of the substitution of heroin
for prescription opioids, although evidence on this is
conflicting [7, 31, 32].
Nor should attention be limited to the risks of pre-
scription opioids. Deaths involving sedatives, especially
benzodiazepines, have grown even faster in percentage
terms, and involvement of these drugs and of psycho-
tropic medications is particularly severely understated
on death certificates. Attention has been paid to the role
of non-opioids and to combination drug use, but a
better understanding is needed since opioids and benzo-
diazepines are often combined, with greater resulting
health risks than the use of either alone [2, 8, 33, 34]. In
a more general sense, comprehensive efforts to reduce
drug fatalities should account for potential therapeutic
benefits and substitution between drugs, the frequency
of combination drug use, and the heterogeneity in levels
and growth of drug mortality across geographic areas
and demographic groups [2, 35, 36].
The results of this analysis are subject to additional
caveats. First, the drugs identified as contributing to
fatal drug poisonings may sometimes be reported in-
accurately. For instance, heroin use may sometimes be
misattributed to morphine or codeine, because heroin
metabolizes into morphine and codeine may be detected
as an impurity in either morphine or heroin [37]. Second,
some deaths could be misclassified as being due to non-
drug causes, and therefore be excluded from the analysis,
while others that are defined as drug poisonings may
actually primarily result from non-drug causes. Third, the
adjustment procedures do not fully correct for cases
where death certificates mention both unspecified and
specified types of drugs. Fourth, information on specific
drug involvement was not available on death certificates,
and so not examined here, for the small number of cases
(732 in 1999 and 637 in 2012) where the underlying cause
was classified as a mental or behavior disorder due to
drug use (ICD-10 codes F11 through F16). Fifth, while
population-wide adjusted proportions are provided, it
would be useful to obtain estimates for subcategories.
However, the precision of such estimates will be limited
for groups where the number of deaths is small, and this
is likely to make it difficult to construct age-adjusted
proportions using finely defined age categories. Finally, fu-
ture research should examine whether these adjustments
change the estimated consequences of policies potentially
affecting drug deaths, such as those related to prescription
drug monitoring programs, internet pharmacies, and
medical cannabis laws [29, 38, 39].
Conclusions
Death certificates substantially understate the frequency of
involvement of opioid analgesics, sedatives, psychotropics,
and combinations of drugs in fatal drug poisonings.
Adjustment procedures that account for cases where only
unspecified drugs are reported on death certificates pro-
vide more accurate and informative estimates.
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